The Latest: Vaccine production halts at Baltimore factory
BALTIMORE — A key contract manufacturer for Johnson & Johnson’s COVID-19 vaccine has stopped making bulk vaccine substance and is retaining what’s already been made at its Baltimore Bayview factory while U.S.